Negative Pressure Wound Therapy Devices Market Study

Negative Pressure Wound Therapy Devices Market Study

Negative Pressure Wound Therapy (NPWT) Devices Market - by Product (Single-use NPWT Device and Conventional NPWT Device), Wound Type (Chronic Wound and Acute Wound), and End User (Hospital & Clinic, Ambulatory Surgical Center, and Home Care Setting) - Global Opportunity Analysis and Industry Forecast, 2017-2025
  • Life Science
  • KDMI-4216
  • MAY 2019
  • Pages: 0
  • Status : Published
  • Views: 265
  • Share:           
BOGO Offer (Buy 1 Get 1) till 31th Dec 2019. Order Now

Negative Pressure Wound Therapy Devices Market Research Study

The analysis of this study offers extensive and highly detailed current as well as future market trends in the global and regional/markets. The study of Negative Pressure Wound Therapy Devices Market involves market size, Y-o-Y growth analysis and a detailed structure of the overall industry. The market analysis is based upon a unique combination of industry research, market sizing analysis, and our in-house expertise. The report also highlights the competitive landscape of Negative Pressure Wound Therapy Devices Market, including market share & positioning of all the prominent key players in the industry.

Negative pressure wound therapy systems are some of the most-commonly used therapies to treat acute and chronic wounds. They promote wound healing, reduce recurrent use of dressings (as in case of traditional wound care), provide an efficient option for management of closed surgical incision lines, and improve patient well-being. These consist of a vacuum pump, drainage tubing, and dressing set. The vacuum pump is either fixed or moveable and is powered by alternating current or batteries. It is designed to regulate suction strength and includes features such as alarm indication for loss of suction and a replaceable collection canister. Dressing sets contain either foam or gauze dressing to be placed on the wounds and an adhesive film drape to seal wounds. Drainage tubes are available in several configurations depending on the dressings used and the wound being treated.

The global negative pressure wound therapy (NPWT) devices market was valued at $2,202 million in 2017 and is projected to reach $2,948 million by 2025 at a CAGR of 3.5% from 2018 to 2025. The growth of the global NPWT devices market is majorly driven by increase in the incidence of chronic diseases such as diabetes mellitus and obesity. The other factors boosting the market growth include rise in patient awareness toward the availability of cost-effective NPWT devices such as single-use devices and technological advancement in NPWT devices. However, lack of trained professionals and complications caused due to the usage of NPWT devices hinder the growth of the global market. On the contrary, increased focus on advancement of treatment protocols, significant unmet needs in the wound care field, and high market potential in untapped emerging economies are anticipated to serve as lucrative opportunities for market expansion.

The global NPWT devices market is segmented based on product, wound type, end user, and region. On the basis of product, the market is bifurcated into single-use NPWT device and conventional NPWT device. As per wound type, it is categorized into chronic wound and acute wound. The chronic wound segment is further classified into pressure ulcer, diabetic foot ulcer, venous leg ulcer, and arterial ulcer. On the other hand, the acute wound segment is sub-segmented into burn & trauma and surgical wound. Considering the end user segment, the market is segregated into hospital & clinic, ambulatory surgery center (ASC), and home care setting. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

- The study provides an in-depth analysis of the global negative pressure wound therapy (NPWT) devices market along with the current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
- A comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that influence this market on global and regional scales are provided.
- The key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Product

- Single-use NPWT device
- Conventional NPWT device

By Wound Type

- Chronic wound
- Pressure ulcer
- Diabetic foot ulcer
- Venous leg ulcer
- Arterial ulcer
- Acute wound
- Burn & trauma
- Surgical wound

By End User

- Hospital & clinic
- Ambulatory surgery center (ASC)
- Home care setting

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

- Acelity L.P., Inc.
- Smith & Nephew plc
- ConvaTec Group plc
- Mlnlycke Health Care AB
- Cardinal Health
- Medela AG
- Devon International Group (Devon Medical Products)
- ATMOS MedizinTechnik GmbH & Co. KG
- Talley Group Ltd.
- DeRoyal Industries, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

- Wuhan VSD Medical Science & Technology Co., Ltd.
- Triage Meditech Pvt. Ltd.
- SunMed Medical
- The Wound Vac Company, LLC.

Request for Sample Pages Click here

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Market share analysis, 2017
3.4. Reimbursement scenario

3.4.1. Favorable reimbursement policies for PICO NPWT system to stimulate the market growth

3.4.1.1. Current Procedural Technology (CPT) codes
3.4.1.2. Healthcare Common Procedure Coding System (HCPCS) codes

3.5. Government regulations

3.5.1. U.S. FDA
3.5.2. Europe CE mark
3.5.3. Ministry of Health, Labour and Welfare (MHLW)

3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Rapidly aging population and favorable demographics worldwide
3.6.1.2. Rise in incidence of chronic conditions
3.6.1.3. Technological advancements in NPWT devices to deal with complex wounds
3.6.1.4. Increased awareness to reduce healthcare costs

3.6.2. Restraints

3.6.2.1. Unnoticed complications of NPWT
3.6.2.2. Need for experienced caregivers

3.6.3. Opportunities

3.6.3.1. Increased focus toward advanced treatment protocols
3.6.3.2. Significant unmet needs in wound care
3.6.3.3. Opportunities in the emerging markets

3.6.4. Impact analyses

3.7. Clinical trials

CHAPTER 4: NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Single-use NPWT devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Conventional NPWT devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET, BY WOUND TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Chronic wounds

5.2.1. Market size and forecast, by type

5.2.1.1. Pressure ulcers

5.2.1.1.1. Market size and forecast

5.2.1.2. Diabetic foot ulcers

5.2.1.2.1. Market size and forecast

5.2.1.3. Venous leg ulcers

5.2.1.3.1. Market size and forecast

5.2.1.4. Arterial ulcers

5.2.1.4.1. Market size and forecast

5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country

5.3. Acute wounds

5.3.1. Market size and forecast, by type

5.3.1.1. Burns & trauma

5.3.1.1.1. Market size and forecast

5.3.1.2. Surgical wounds

5.3.1.2.1. Market size and forecast

5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country

CHAPTER 6: NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals & clinics

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Ambulatory surgery centers (ASCs)

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Home care settings

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America negative pressure wound therapy (NPWT) devices market, by country

7.2.2.1. U.S.

7.2.2.1.1. Market size and forecast, by product
7.2.2.1.2. Market size and forecast, by wound type
7.2.2.1.3. Market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Market size and forecast, by product
7.2.2.2.2. Market size and forecast, by wound type
7.2.2.2.3. Market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Market size and forecast, by product
7.2.2.3.2. Market size and forecast, by wound type
7.2.2.3.3. Market size and forecast, by end user

7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by wound type
7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Market size and forecast, by product
7.3.2.1.2. Market size and forecast, by wound type
7.3.2.1.3. Market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. Market size and forecast, by product
7.3.2.2.2. Market size and forecast, by wound type
7.3.2.2.3. Market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. Market size and forecast, by product
7.3.2.3.2. Market size and forecast, by wound type
7.3.2.3.3. Market size and forecast, by end user

7.3.2.4. Italy

7.3.2.4.1. Market size and forecast, by product
7.3.2.4.2. Market size and forecast, by wound type
7.3.2.4.3. Market size and forecast, by end user

7.3.2.5. Spain

7.3.2.5.1. Market size and forecast, by product
7.3.2.5.2. Market size and forecast, by wound type
7.3.2.5.3. Market size and forecast, by end user

7.3.3. Rest of Europe

7.3.3.1.1. Market size and forecast, by product
7.3.3.1.2. Market size and forecast, by wound type
7.3.3.1.3. Market size and forecast, by end user

7.3.4. Europe market size and forecast, by product
7.3.5. Europe market size and forecast, by wound type
7.3.6. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Market size and forecast, by product
7.4.2.1.2. Market size and forecast, by wound type
7.4.2.1.3. Market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. Market size and forecast, by product
7.4.2.2.2. Market size and forecast, by wound type
7.4.2.2.3. Market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. Market size and forecast, by product
7.4.2.3.2. Market size and forecast, by wound type
7.4.2.3.3. Market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Market size and forecast, by product
7.4.2.4.2. Market size and forecast, by wound type
7.4.2.4.3. Market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. Market size and forecast, by product
7.4.2.5.2. Market size and forecast, by wound type
7.4.2.5.3. Market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Market size and forecast, by product
7.4.2.6.2. Market size and forecast, by wound type
7.4.2.6.3. Market size and forecast, by end user

7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by wound type
7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Market size and forecast, by product
7.5.2.1.2. Market size and forecast, by wound type
7.5.2.1.3. Market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Market size and forecast, by product
7.5.2.2.2. Market size and forecast, by wound type
7.5.2.2.3. Market size and forecast, by end user

7.5.2.3. UAE

7.5.2.3.1. Market size and forecast, by product
7.5.2.3.2. Market size and forecast, by wound type
7.5.2.3.3. Market size and forecast, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Market size and forecast, by product
7.5.2.4.2. Market size and forecast, by wound type
7.5.2.4.3. Market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by wound type
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. ACELITY L.P. INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating product segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments

8.2. ATMOS MedizinTechnik GmbH & Co. KG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio

8.3. Cardinal Health

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. ConvaTec Group Plc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. DeRoyal Industries, Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product Portfolio

8.6. Devon International Group (Devon Medical Products)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product Portfolio

8.7. Mlnlycke Health Care AB. (A subsidiary of INVESTOR AB)

8.7.1. Company Overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product Portfolio
8.7.5. Business performance

8.8. Olle Larsson Holding AG (Medela AG)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments

8.9. Smith & Nephew Plc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Talley Group Ltd

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Product Portfolio

Need Assistance


+1 (518) 300-1215

or

[email protected]

Request Sample Ask An Analyst Request Discount Request Methodology